Nafcillin
Nafcillin for Injection, USPFor Intramuscular or Intravenous Injection
Approved
Approval ID
8a00624c-c436-4102-a042-dab54022bcc2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 20, 2025
Manufacturers
FDA
Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.
DUNS: 780779901
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nafcillin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code23155-907
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin Sodium
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 20, 2025
FDA Product Classification
INGREDIENTS (2)
NAFCILLIN SODIUMActive
Quantity: 2 g in 8 mL
Code: 49G3001BCK
Classification: ACTIM
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
Nafcillin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code23155-906
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin Sodium
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 20, 2025
FDA Product Classification
INGREDIENTS (2)
NAFCILLIN SODIUMActive
Quantity: 1 g in 4 mL
Code: 49G3001BCK
Classification: ACTIM
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT